Guest account
Sign in to access your account
HPLC Tested
MS verified
COA included
$64.95
Half-life
na multi-component
Purity
≥ 99.6%
Mw
~3647 g/mol; ~711.9 g/mol
In stock
CJC-1295/Ipamorelin is a combination peptide therapy prescribed by physicians to stimulate endogenous growth hormone (GH) release, primarily for managing adult-onset GH deficiency, age-related decline, muscle growth, fat loss, and recovery. CJC-1295, a long-acting analog of GH-releasing hormone (GHRH), promotes sustained GH and insulin-like growth factor-1 (IGF-1) increases, while Ipamorelin, a selective GH secretagogue mimicking ghrelin, enhances GH pulses for synergistic effects.
Mechanism of action
GHRH analog (CJC) + selective GHSR agonist (Ipamorelin); synergistically stimulate pulsatile pituitary GH release, elevate IGF-1, promote lipolysis/muscle growth with minimal off-target hormones in endocrine, metabolic, and performance research models.
Lyophilized: −20°C, 18-month shelf life. Post-reconstitution: 4°C.
Add 2 mL bacteriostatic water. Swirl gently. Stable 28 days refrigerated post-reconstitution.
Identity + purity
MW verified
USP <71> compliant
Full COA ships with every order including HPLC trace, mass spec, and per-batch purity percentage.